Zare-Bidaki Mohammad, Ayoobi Fatemeh, Hassanshahi Gholamhossein, Arababadi Mohammad Kazemi, Mirzaei Tayebeh, Darehdori Ahmad Shebanizade, Kennedy Derek
Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Physiology-Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Clin Lab. 2014;60(1):9-21. doi: 10.7754/clin.lab.2013.130206.
Hepatitis B virus (HBV) is a serious risk factor for several severe liver diseases such as cirrhosis and hepatocellular carcinoma. HBV, like other viruses, uses several mechanisms to escape from specific immune responses including the use of mutations in the genome which lead to epitope variations. There are several immune responses, including T helper cells, cytotoxic T lymphocytes, and B cells, against the core antigen of HBV (HBcAg) that can lead to HBV eradication. Therefore, mutations within the HBc gene can lead to escape from immune responses by HBV and, hence, understanding the prevalence of HBc mutations among a specific population can be helpful for future treatment and vaccination. This review addresses the recent information regarding the prevalence of mutations within the HBc gene among Iranian HBV infected patients.
The data presented here was collected gene sequences reported from Iran to the NCBI nucleotide Gen Bank.
Results showed that the prevalence of HBc gene mutations is frequent in Iranian HBV infected patients.
Based on our searches it seems that escape from immune responses is a plausible reason for the high prevalence of HBc gene mutations among Iranian HBV infected patients.
乙型肝炎病毒(HBV)是导致肝硬化和肝细胞癌等几种严重肝脏疾病的重要危险因素。与其他病毒一样,HBV利用多种机制逃避特异性免疫反应,包括利用基因组中的突变导致表位变异。存在多种针对HBV核心抗原(HBcAg)的免疫反应,包括辅助性T细胞、细胞毒性T淋巴细胞和B细胞,这些反应可导致HBV被清除。因此,HBc基因内的突变可导致HBV逃避免疫反应,所以了解特定人群中HBc突变的流行情况有助于未来的治疗和疫苗接种。本综述阐述了有关伊朗HBV感染患者中HBc基因突变流行情况的最新信息。
此处呈现的数据收集自伊朗上报至NCBI核苷酸基因库的基因序列。
结果显示,伊朗HBV感染患者中HBc基因突变很常见。
基于我们的检索,免疫反应逃逸似乎是伊朗HBV感染患者中HBc基因突变高流行率的一个合理原因。